Cargando…

Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women

BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most important contributing factors to infertility. The diagnosis of PCOS is not an easy procedure, as the signs and symptoms are heterogeneous and of undefined etiology. There are only a few published studies that address the diagnostic per...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhassan, Samia, Elmugadam, Abdelgadir, Elfadil, Ghada A, Abubaker, Nuha, Elfaki, Elyasa M, Hamza, Alneil, Abdalhabib, Ezeldine K, Karar, Tarig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237195/
https://www.ncbi.nlm.nih.gov/pubmed/37275514
http://dx.doi.org/10.2147/IJWH.S403347
_version_ 1785053107834585088
author Alhassan, Samia
Elmugadam, Abdelgadir
Elfadil, Ghada A
Abubaker, Nuha
Elfaki, Elyasa M
Hamza, Alneil
Abdalhabib, Ezeldine K
Karar, Tarig
author_facet Alhassan, Samia
Elmugadam, Abdelgadir
Elfadil, Ghada A
Abubaker, Nuha
Elfaki, Elyasa M
Hamza, Alneil
Abdalhabib, Ezeldine K
Karar, Tarig
author_sort Alhassan, Samia
collection PubMed
description BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most important contributing factors to infertility. The diagnosis of PCOS is not an easy procedure, as the signs and symptoms are heterogeneous and of undefined etiology. There are only a few published studies that address the diagnostic performance of anti-Müllerian hormone in diagnosis of PCOS in sub-Saharan Africa including Sudan. OBJECTIVE: This study aims to assess anti-Müllerian hormone (AMH), luteinizing to follicle-stimulating hormone ratio (LH: FSH), total testosterone (TT), and prolactin (PRL) levels among PCOS. In addition, we determine if AMH can be used as a predictor of PCOS among Sudanese women. METHODS: There were 600 women enrolled in this observational cross-sectional study, 300 of whom had PCOS, and 300 of whom healthy women; PCOS was diagnosed using the Rotterdam criteria. On days 2–4 of the menstrual cycle, serum LH, FSH, AMH, TT, and PRL levels were measured for all participants. Diagnostic performance of these parameters for PCOS was determined by receiver operating characteristic (ROC) curve. RESULTS: Significantly higher means among PCOS regarding their BMI, AMH; LH: FSH ratio; TT; PRL, whereas significantly inverse in FSH compared with normal ovulatory women. On ROC analysis, AMH had the largest operating characteristic curve at cut-off >3.95 ng/mL; AUC = 0.999 with Youden’s index 0.99%, followed by LH: FSH ratio at cut-off 0.749; AUC=0.932; Youden’s index 0.813%, TT cut-off 0.82 mIU/L, AUC=0.852 with Youden’s index 0.58, while PRL showed the lowest AUC=0.627 with cut-off 15.3 ng/mL, Youden’s index was 0.18%, P. value<0.001. CONCLUSIONS: Sudanese women with PCOS had higher serum AMH level, LH:FSH ratio, and TT level. Moreover, AMH level has better discriminative power and good diagnostic potency for the diagnosis of PCOS among Sudanese.
format Online
Article
Text
id pubmed-10237195
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102371952023-06-03 Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women Alhassan, Samia Elmugadam, Abdelgadir Elfadil, Ghada A Abubaker, Nuha Elfaki, Elyasa M Hamza, Alneil Abdalhabib, Ezeldine K Karar, Tarig Int J Womens Health Original Research BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most important contributing factors to infertility. The diagnosis of PCOS is not an easy procedure, as the signs and symptoms are heterogeneous and of undefined etiology. There are only a few published studies that address the diagnostic performance of anti-Müllerian hormone in diagnosis of PCOS in sub-Saharan Africa including Sudan. OBJECTIVE: This study aims to assess anti-Müllerian hormone (AMH), luteinizing to follicle-stimulating hormone ratio (LH: FSH), total testosterone (TT), and prolactin (PRL) levels among PCOS. In addition, we determine if AMH can be used as a predictor of PCOS among Sudanese women. METHODS: There were 600 women enrolled in this observational cross-sectional study, 300 of whom had PCOS, and 300 of whom healthy women; PCOS was diagnosed using the Rotterdam criteria. On days 2–4 of the menstrual cycle, serum LH, FSH, AMH, TT, and PRL levels were measured for all participants. Diagnostic performance of these parameters for PCOS was determined by receiver operating characteristic (ROC) curve. RESULTS: Significantly higher means among PCOS regarding their BMI, AMH; LH: FSH ratio; TT; PRL, whereas significantly inverse in FSH compared with normal ovulatory women. On ROC analysis, AMH had the largest operating characteristic curve at cut-off >3.95 ng/mL; AUC = 0.999 with Youden’s index 0.99%, followed by LH: FSH ratio at cut-off 0.749; AUC=0.932; Youden’s index 0.813%, TT cut-off 0.82 mIU/L, AUC=0.852 with Youden’s index 0.58, while PRL showed the lowest AUC=0.627 with cut-off 15.3 ng/mL, Youden’s index was 0.18%, P. value<0.001. CONCLUSIONS: Sudanese women with PCOS had higher serum AMH level, LH:FSH ratio, and TT level. Moreover, AMH level has better discriminative power and good diagnostic potency for the diagnosis of PCOS among Sudanese. Dove 2023-05-29 /pmc/articles/PMC10237195/ /pubmed/37275514 http://dx.doi.org/10.2147/IJWH.S403347 Text en © 2023 Alhassan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Alhassan, Samia
Elmugadam, Abdelgadir
Elfadil, Ghada A
Abubaker, Nuha
Elfaki, Elyasa M
Hamza, Alneil
Abdalhabib, Ezeldine K
Karar, Tarig
Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
title Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
title_full Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
title_fullStr Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
title_full_unstemmed Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
title_short Diagnostic Performance of Anti-Müllerian Hormone, Luteinizing Hormone to Follicle-Stimulating Hormone Ratio, Testosterone, and Prolactin to Predict Polycystic Ovary Syndrome Among Sudanese Women
title_sort diagnostic performance of anti-müllerian hormone, luteinizing hormone to follicle-stimulating hormone ratio, testosterone, and prolactin to predict polycystic ovary syndrome among sudanese women
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237195/
https://www.ncbi.nlm.nih.gov/pubmed/37275514
http://dx.doi.org/10.2147/IJWH.S403347
work_keys_str_mv AT alhassansamia diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen
AT elmugadamabdelgadir diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen
AT elfadilghadaa diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen
AT abubakernuha diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen
AT elfakielyasam diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen
AT hamzaalneil diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen
AT abdalhabibezeldinek diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen
AT karartarig diagnosticperformanceofantimullerianhormoneluteinizinghormonetofolliclestimulatinghormoneratiotestosteroneandprolactintopredictpolycysticovarysyndromeamongsudanesewomen